Unlocking the Promise of Antitumor Hyperthermia‐Immunotherapy with Spiky Surface Topology
Advanced Science · 2025
DOI: 10.1002/advs.202415868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Muyue Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 200011, China. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Immunotherapy, Melanoma, Uveal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai, Shanghai Eye Disease Research Center, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Uveal melanoma (UM) is the most prevalent primary intraocular malignant tumor in adults with high mortality rate. Recently, immunotherapy has shown great success in other tumors, however, its therapeutic effect in UM is unsatisfactory, possibly due to the insufficient immune cell infiltration and low immunogenicity of UM. Thus, an efficient therapeutic strategy to reverse the immunosuppressive tumor microenvironment is required. Herein, a PD‐L1 modified hierarchical structure consisting of a magnetic Fe 3 O 4 core and spiky silica shell (MNP@Spiky/PD‐L1) is developed to reverse the immunosuppressive tumor microenvironment and trigger powerful antitumor immune responses. The MNP@Spiky can induce enhanced immunogenic cell death as well as physical activation of innate immunity. First, tumor cells are disrupted directly by magnetic hyperthermia effect and released tumor‐associated antigens to initiate anti‐tumor immune responses. Meanwhile, the spiky surface of MNP@Spiky augmented tumor antigen uptake as well as maturation of dendritic cells through inflammasome activation. By further associating with PD‐L1‐targeting antibody, MNP@Spiky/PD‐L1 reversed the immunosuppressive tumor microenvironment and triggered powerful antitumor immune responses. Overall, this synergistic therapeutic strategy effectively reprogramed tumor microenvironment and achieved tumor eradication, which sheds light on clinical UM immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 200011, China.
- State Key Laboratory of Eye Health, Shanghai Jiao Tong University, Shanghai, 200011, China.
- Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200011, China.
- Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers, Laboratory of Advanced Materials, Fudan University, Shanghai, 200433, China.
ORCID-Profile: Xianqun Fan
Förderung
- Science and Technology Commission of Shanghai
- Shanghai Eye Disease Research Center
- Shanghai Jiao Tong University
- China Postdoctoral Science Foundation
- Shanghai Ninth People's Hospital
Zitieren
APA
Yang, M., Yu, Y., Ge, T., Zhu, Q., Zhuang, A., Wang, W., & Fan, X. (2025). Unlocking the Promise of Antitumor Hyperthermia‐Immunotherapy with Spiky Surface Topology. Advanced Science. https://doi.org/10.1002/advs.202415868
Vancouver
Yang M, Yu Y, Ge T, Zhu Q, Zhuang A, Wang W, et al. Unlocking the Promise of Antitumor Hyperthermia‐Immunotherapy with Spiky Surface Topology. Advanced Science. 2025. doi:10.1002/advs.202415868
BibTeX
@article{Yang2025,
author = {Yang, Muyue and Yu, Yan and Ge, Tongxin and Zhu, Qiuyi and Zhuang, Ai and Wang, Wenxing and Fan, Xianqun},
title = {Unlocking the Promise of Antitumor Hyperthermia‐Immunotherapy with Spiky Surface Topology},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202415868}
}
EUVIMED